Effect of Mutations at Serines 1280Graphic1283 on the Mitogenic and Transforming Activities of the Insulin-like Growth Factor I Receptor (*)

  1. Shiwei Li,
  2. Mariana Resnicoff and
  3. Renato Baserga(§)
  1. From the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
  1. § To whom correspondence should be addressed. Tel.: 215-503-4507; Fax: 215-923-0249.

Abstract

The insulin-like growth factor I receptor (IGF-IR) controls the extent of cell proliferation in a variety of cell types by at least 3 different ways: it is mitogenic, it causes transformation, and it protects cells from apoptosis. Previous reports indicated that certain domains in the C terminus of the IGF-IR transmitted a transforming signal that is additional to and separate from the mitogenic signal. We have now mutated the four serine residues at 1280-1283 of the IGF-IR, and transfected the mutant receptor into RGraphic cells. Cells expressing the mutant receptor are fully responsive to IGF-I-mediated mitogenesis, but are not transformed (no colony formation in soft agar). Several downstream signal transducers are not affected by the mutation, again suggesting a separate pathway for transformation. The mutant receptor can act as a dominant negative for growth, but cannot induce apoptosis in cells with endogenous wild-type receptors.

Footnotes

  • * This work has been supported by funds from the National Institutes of Health, National Institute on Aging Grant AG00378. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • (Graphic) The abbreviations used are:

    IGF-IR

    insulin-like growth factor I receptor

    IGF-I or II

    insulin-like growth factor I or II

    IR

    insulin receptor

    SFM

    serum-free medium

    PCR

    polymerase chain reaction

    PI-3

    phosphoinositide 3

    MAP

    mitogen-activated protein

    PCR

    polymerase chain reaction

    DMEM

    Dulbecco's modified Eagle's medium

    PAGE

    polyacrylamide gel electrophoresis

    IRS-1

    insulin receptor substrate-1.

  • (Graphic) J.-L. Burgaud and R. Baserga, submitted for publication.

  • (Graphic) C. D'Ambrosio, A. Ferber, M. Resnicoff, and R. Baserga, unpublished data.

    • Received October 31, 1995.
    • Revision received January 5, 1996.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement